Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness
Takeda's Plasma-Derived Therapies: Challenges and Growth in a Concentrated Market
Takeda's plasma-derived therapies (PDT) business, generating $5.98 billion in 2023 (21% of total revenue), faces challenges due to concentrated plasma sourcing (90% from 5 countries) and increasing global demand projected to reach $46.7 billion by 2031; Takeda is addressing this through process impr...
Takeda's Plasma-Derived Therapies: Challenges and Growth in a Concentrated Market
Takeda's plasma-derived therapies (PDT) business, generating $5.98 billion in 2023 (21% of total revenue), faces challenges due to concentrated plasma sourcing (90% from 5 countries) and increasing global demand projected to reach $46.7 billion by 2031; Takeda is addressing this through process impr...
Progress
24% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results